The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

OBJECTIVE: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cardiol Heart Vasc
Autors principals: Braude, Philip, Carter, Ben, Short, Roxanna, Vilches-Moraga, Arturo, Verduri, Alessia, Pearce, Lyndsay, Price, Angeline, Quinn, Terence J., Stechman, Michael, Collins, Jemima, Bruce, Eilidh, Einarsson, Alice, Rickard, Frances, Mitchell, Emma, Holloway, Mark, Hesford, James, Barlow-Pay, Fenella, Clini, Enrico, Myint, Phyo Kyaw, Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7561344/
https://ncbi.nlm.nih.gov/pubmed/33083516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars